Synbio Tech Inc.
Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional s… Read more
Market Cap & Net Worth: Synbio Tech Inc. (1295)
Synbio Tech Inc. (TWO:1295) has a market capitalization of $19.81K (NT$655.58K) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #43789 globally and #1942 in its home market, demonstrating a -2.72% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Synbio Tech Inc.'s stock price NT$71.50 by its total outstanding shares 9169 (9.17K).
Synbio Tech Inc. Market Cap History: 2026 to 2026
Synbio Tech Inc.'s market capitalization history from 2026 to 2026. Data shows growth from $19.81K to $19.81K (0.00% CAGR).
Synbio Tech Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Synbio Tech Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 1295 by Market Capitalization
Companies near Synbio Tech Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to Synbio Tech Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Synbio Tech Inc. Historical Marketcap From 2026 to 2026
Between 2026 and today, Synbio Tech Inc.'s market cap moved from $19.81K to $ 19.81K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$19.81K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Synbio Tech Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $19.81K USD |
| MoneyControl | $19.81K USD |
| MarketWatch | $19.81K USD |
| marketcap.company | $19.81K USD |
| Reuters | $19.81K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.